{"id":23904,"date":"2014-09-12T12:51:17","date_gmt":"2014-09-12T17:51:17","guid":{"rendered":"https:\/\/brakkeconsulting.com\/?p=23904"},"modified":"2018-04-14T02:10:15","modified_gmt":"2018-04-14T07:10:15","slug":"23904","status":"publish","type":"post","link":"https:\/\/brakkeconsulting.com\/zh\/23904\/","title":{"rendered":"2014 \u5e74 9 \u6708 12 \u65e5\u52a8\u7269\u5065\u5eb7\u65b0\u95fb\u4e0e\u6ce8\u91ca"},"content":{"rendered":"<p><a target=\"_blank\" href=\"\/wp-content\/uploads\/2018\/01\/AHN_9_12_14.pdf\">\u6253\u5370\u7248\u672c<\/a><\/p>\n<p>***********************************<br \/>\n<strong>Brakke \u54a8\u8be2\u516c\u53f8\u7684 <br \/>\n2014 \u5e74 9 \u6708 12 \u65e5\u52a8\u7269\u5065\u5eb7\u65b0\u95fb\u4e0e\u6ce8\u91ca<\/strong><br \/>\n\u7248\u6743\u6240\u6709 \u00a9 Brakke \u54a8\u8be2\u516c\u53f8<br \/>\n&nbsp;<br \/>\n\u7f16\u8f91\uff1aLynn Fondon DVM MBA<br \/>\n************************************<br \/>\n\u65b0\u95fb\u62a5\u9053\uff1a<br \/>\n&nbsp;<br \/>\n<u>Brakke \u54a8\u8be2\u65b0\u95fb<\/u><br \/>\n2014 \u5e74\u732b\u72d7\u764c\u75c7<br \/>\n\u4ea4\u6613\u534f\u52a9<br \/>\n&nbsp;<br \/>\n<u>\u76c8\u5229\u65b0\u95fb<\/u><br \/>\n\u5927\u5fc3\u5ba0\u7269\u54c1\u724c<br \/>\n\u5fb7\u514b\u62c9 <br \/>\n\u5c5e<br \/>\n\u6851\u5fb7\u68ee\u519c\u573a<br \/>\n&nbsp;<br \/>\n<u>\u5176\u4ed6\u65b0\u95fb<\/u><br \/>\nAlivira \u52a8\u7269\u4fdd\u5065 <br \/>\n\u4f53\u5185<br \/>\n\u9ed8\u514b<br \/>\n\u6f58\u79d1\u65af\u739b<br \/>\nProvet \u517d\u533b\u4ea7\u54c1<br \/>\n\u517d\u533b\u5ba0\u7269\u4fdd\u9669&nbsp; <br \/>\n&nbsp;<br \/>\n************************************<br \/>\n<strong>\u5341\u6708\u5373\u5c06\u63a8\u51fa<br \/>\n\u5e03\u62c9\u514b\u54a8\u8be2\u6709\u9650\u516c\u53f8<br \/>\n\u65b0\u62a5\u544a\uff1a2014 \u5e74\u72d7\u548c\u732b\u7684\u764c\u75c7<br \/>\n\u63d0\u524d\u8ba2\u8d2d\u6298\u6263\u5c06\u4e8e 9 \u6708 19 \u65e5\u7ed3\u675f\uff01<\/strong><\/p>\n<p>2009 \u5e74\uff0cBrakke Consulting \u53d1\u8868\u4e86\u5173\u4e8e\u72d7\u548c\u732b\u764c\u75c7\u6cbb\u7597\u7684\u6982\u8ff0\u3002\u6211\u4eec\u5f88\u9ad8\u5174\u5730\u5ba3\u5e03\uff0c\u8fd9\u4efd\u5907\u53d7\u63a8\u5d07\u7684\u62a5\u544a\u7684\u66f4\u65b0\u7248\u5c06\u4e8e\u4eca\u5e74 10 \u6708\u53d1\u5e03\u3002<\/p>\n<p>2014 \u5e74\u764c\u75c7\u7814\u7a76\u5305\u62ec\u5e38\u89c1\u517d\u533b\u764c\u75c7\u7684\u53d1\u75c5\u7387\u3001\u8bca\u65ad\u548c\u6cbb\u7597\u4fe1\u606f\uff0c\u5305\u62ec\u6cbb\u7597\u8d39\u7528\u4f30\u7b97\u3002\u8be5\u7814\u7a76\u5305\u62ec\u5bf9 250 \u540d\u666e\u901a\u517d\u533b\u7684\u8c03\u67e5\u4ee5\u53ca\u5bf9\u517d\u533b\u80bf\u7624\u5b66\u5bb6\u7684\u91c7\u8bbf\u3002\u62a5\u544a\u4e2d\u8fd8\u5305\u542b\u5bf9\u65b0\u578b\u548c\u6b63\u5728\u5f00\u53d1\u7684\u517d\u533b\u764c\u75c7\u5316\u7597\u836f\u7269\u7684\u8bc4\u8bba\u3002<\/p>\n<p>\u8be5\u62a5\u544a\u7684\u9884\u8ba2\u4ef7\u683c\u4e3a $7,750\uff0c\u622a\u81f3 9 \u6708 19 \u65e5\u3002\u5982\u9700\u66f4\u591a\u4fe1\u606f\uff0c\u8bf7\u8bbf\u95ee\u6211\u4eec\u7684\u7f51\u7ad9\u6216\u8054\u7cfb Lynn Fondon \u535a\u58eb <a href=\"mailto:lfondon@brakkeconsulting.com\">lfondon@brakkeconsulting.com<\/a>. <br \/>\n&nbsp;<br \/>\n<a href=\"http:\/\/www.BrakkeConsulting.com\">www.BrakkeConsulting.com<\/a> <br \/>\n&nbsp;<br \/>\n************************************<br \/>\n\u516c\u53f8\u4e1a\u7ee9\u53d1\u5e03<br \/>\n&nbsp;<br \/>\n&gt; Dechra Pharmaceuticals \u516c\u5e03\u4e86\u622a\u81f3 2014 \u5e74 6 \u6708 30 \u65e5\u7684 12 \u4e2a\u6708\u4e1a\u7ee9\u3002\u672c\u8d22\u5e74\u6536\u5165\u8fbe\u5230 1.94 \u4ebf\u82f1\u9551\uff08$3.12 \u4ebf\u82f1\u9551\uff09\uff0c\u4e0e\u4e0a\u4e00\u5e74\u6301\u7eed\u7ecf\u8425\u76f8\u6bd4\u589e\u957f 2%\u3002\u836f\u54c1\u603b\u9500\u552e\u989d\u6500\u5347 1.5% \u81f3 1.47 \u4ebf\u82f1\u9551\uff08$2.36 \u4ebf\u82f1\u9551\uff09\u3002\u8be5\u516c\u53f8 2014 \u8d22\u5e74\u7684\u57fa\u672c EBITDA \u4e3a 4600 \u4e07\u82f1\u9551\uff08$74 \u4ebf\u82f1\u9551\uff09\uff0c\u4e0e\u4e0a\u4e00\u5e74\u76f8\u6bd4\u589e\u957f 8%\u3002\uff08\u516c\u53f8\u7f51\u7ad9\uff09&nbsp; <br \/>\n&nbsp;<br \/>\n&gt; Big Heart Pet Brands \u516c\u5e03\u4e86\u622a\u81f3 2014 \u5e74 7 \u6708 27 \u65e5\u7684 2015 \u8d22\u5e74\u7b2c\u4e00\u5b63\u5ea6\u4e1a\u7ee9\u3002\u51c0\u9500\u552e\u989d\u589e\u957f 10% \u81f3 $5.3 \u4ebf\u7f8e\u5143\uff0c\u8fd9\u5f97\u76ca\u4e8e\u4e0a\u5e74\u6536\u8d2d Natural Balance\uff082013 \u5e74 7 \u6708 15 \u65e5\uff09\u5e26\u6765\u7684\u9500\u91cf\u589e\u957f\u4ee5\u53ca\u6574\u4e2a\u4ea7\u54c1\u7ec4\u5408\u4e2d\u65b0\u4ea7\u54c1\u7684\u6210\u529f\u63a8\u51fa\uff0c\u4f46\u90e8\u5206\u62b5\u6d88\u4e86\u67d0\u4e9b\u5229\u6da6\u7387\u8f83\u4f4e\u7684\u5ba0\u7269\u98df\u54c1\u4ea7\u54c1\u9500\u91cf\u4e0b\u964d\u7684\u5f71\u54cd\u3002\u51c0\u6536\u5165\u4e0b\u964d 43% \u81f3 $1130 \u4e07\u7f8e\u5143\uff0c\u90e8\u5206\u539f\u56e0\u662f\u73b0\u91d1\u5bf9\u51b2\u5934\u5bf8\u7684\u4e0d\u5229\u5f71\u54cd\u3002\uff08\u516c\u53f8\u65b0\u95fb\u7a3f\uff09 <br \/>\n&nbsp;<br \/>\n&gt; Genus \u516c\u5e03\u4e86\u622a\u81f3 2014 \u5e74 6 \u6708 30 \u65e5\u7684 12 \u4e2a\u6708\u8d22\u52a1\u4e1a\u7ee9\u3002\u8be5\u516c\u53f8\u62a5\u544a\u79f0\uff0c\u5168\u5e74\u8425\u4e1a\u5229\u6da6\u4e3a 4180 \u4e07\u82f1\u9551\uff08$6880 \u4e07\u82f1\u9551\uff09\uff0c\u6536\u5165\u4e3a 3.72 \u4ebf\u82f1\u9551\uff08$6.12 \u4ebf\u82f1\u9551\uff09\uff0c\u9ad8\u4e8e\u4e0a\u4e00\u5e74\u7684 3630 \u4e07\u82f1\u9551\u548c 3.45 \u4ebf\u82f1\u9551\u3002\uff08Animal Pharm\uff09 <br \/>\n&nbsp;<br \/>\n&gt; Sanderson Farms Inc. \u516c\u5e03\u4e86\u622a\u81f3 7 \u6708 31 \u65e5\u7684 2014 \u8d22\u5e74\u7b2c\u4e09\u5b63\u5ea6\u4e1a\u7ee9\u3002\u51c0\u9500\u552e\u989d\u4e3a $7.68 \u4ebf\u7f8e\u5143\uff0c\u6bd4\u53bb\u5e74\u540c\u671f\u589e\u957f 4%\u3002\u51c0\u6536\u5165\u4e3a $7610 \u4e07\u7f8e\u5143\uff0c\u6bd4\u53bb\u5e74\u540c\u671f\u9ad8\u51fa 12%\u3002\uff08\u9972\u6599\uff09 <br \/>\n&nbsp;<br \/>\n************************************<br \/>\n\u516c\u53f8\u65b0\u95fb\u7a3f<br \/>\n&nbsp;<br \/>\n&gt; \u9ed8\u514b\u52a8\u7269\u4fdd\u5065\u516c\u53f8\u5ba3\u5e03\u63a8\u51fa Prime Pac PRRS+\uff0c\u8fd9\u662f\u4e00\u79cd\u75ab\u82d7\uff0c\u7528\u4e8e\u51cf\u5c11\u80b2\u9f84\u6bcd\u732a\u751f\u6b96\u75be\u75c5\u7684\u4e34\u5e8a\u75c7\u72b6\u4ee5\u53ca 3 \u81f3 4 \u5468\u9f84\u53ca\u4ee5\u4e0a\u732a\u56e0\u732a\u751f\u6b96\u4e0e\u547c\u5438\u7efc\u5408\u5f81\u75c5\u6bd2 (PRRSv) \u5f15\u8d77\u7684\u547c\u5438\u9053\u75be\u75c5\u3002\uff08\u516c\u53f8\u65b0\u95fb\u7a3f\uff09&nbsp; <br \/>\n&nbsp;<br \/>\n&gt; \u517d\u533b\u5ba0\u7269\u4fdd\u9669\u7684\u6bcd\u516c\u53f8 Nationwide Mutual Insurance Co. \u5ba3\u5e03\uff0c\u5305\u62ec\u517d\u533b\u5ba0\u7269\u4fdd\u9669\u5728\u5185\u7684\u4e00\u7cfb\u5217\u5b50\u516c\u53f8\u5c06\u5728\u672a\u6765 18 \u4e2a\u6708\u5185\u8fdb\u884c\u54c1\u724c\u91cd\u5851\u3002Nationwide \u7684\u76ee\u6807\u662f\u5c06\u6240\u6709\u4e1a\u52a1\u7eb3\u5165\u540c\u4e00\u4f01\u4e1a\u54c1\u724c\u548c\u66f4\u65b0\u540e\u7684\u5fbd\u6807\u4e4b\u4e0b\u3002\uff08\u517d\u533b\u5b9e\u8df5\u65b0\u95fb\uff09 <br \/>\n&nbsp;<br \/>\n&gt; EU InVivo \u5ba3\u5e03\u5c06\u6536\u8d2d\u745e\u58eb\u9972\u6599\u6dfb\u52a0\u5242\u5236\u9020\u5546 Pancosma\u3002Pancosma \u62e5\u6709\u4e03\u79cd\u4e0d\u540c\u7684\u4ea7\u54c1\u7ebf\uff0c\u5728\u6cd5\u56fd\u3001\u745e\u58eb\u3001\u52a0\u62ff\u5927\u3001\u6ce2\u5170\u548c\u4e2d\u56fd\u8bbe\u6709\u5236\u9020\u5382\u3002\u4ea4\u6613\u7684\u8d22\u52a1\u6761\u6b3e\u5c1a\u672a\u62ab\u9732\u3002\uff08Animal Pharm\uff09&nbsp; <br \/>\n&nbsp;<br \/>\n&gt; \u571f\u8033\u5176 \u5370\u5ea6\u516c\u53f8 Alivira Animal Health \u5ba3\u5e03\u5df2\u6536\u8d2d\u571f\u8033\u5176\u6700\u5927\u7684\u5bb6\u755c\u4fdd\u5065\u516c\u53f8 Provet Veterinary Products \u7684 60% \u80a1\u4efd\u3002\u8fd9\u662f Alivira \u7684\u9996\u6b21\u6536\u8d2d\uff0c\u8be5\u516c\u53f8\u662f Shasun Pharmaceuticals \u548c SeQuent Scientific \u7684\u5408\u8d44\u4f01\u4e1a\u3002\u8d22\u52a1\u6761\u6b3e\u5c1a\u672a\u62ab\u9732\u3002\uff08Animal Pharm\uff09&nbsp; <br \/>\n&nbsp;<br \/>\n***********************************<br \/>\n\u52a8\u7269\u5065\u5eb7\u65b0\u95fb<br \/>\n&nbsp;<br \/>\n&gt; \u7f8e\u56fd \u2013 \u4f4e\u81f4\u75c5\u6027\u79bd\u6d41\u611f \u7f8e\u56fd\u4e94\u5e74\u6765\u9996\u6b21\u62a5\u544a\u4f4e\u81f4\u75c5\u6027\u79bd\u6d41\u611f (LPAI) \u75ab\u60c5\u3002H7 \u75ab\u60c5\u53d1\u751f\u5728\u65b0\u6cfd\u897f\u5dde\u4e1c\u5357\u90e8\u7684\u4e00\u4e2a\u9e2d\u517b\u6b96\u4e2d\u5fc3\u548c\u4fdd\u62a4\u533a\uff0c\u5f71\u54cd\u4e86 48,000 \u53ea\u6613\u611f\u9e1f\u7fa4\u3002\u5df2\u5b9e\u65bd\u68c0\u75ab\u63a7\u5236\u3002\u6ca1\u6709\u75ab\u82d7\u63a5\u79cd\u7b56\u7565\u3002\uff08Animal Pharm\uff09<br \/>\n&nbsp;<br \/>\n&gt; \u7f8e\u56fd \u2013 \u52a8\u7269\u836f\u7269\u6cd5\u89c4 FDA \u5ba3\u5e03\uff0c\u81ea 9 \u6708 9 \u65e5\u8d77\uff0c\u5c06\u5c31\u6269\u5927\u65b0\u52a8\u7269\u836f\u7269\u6709\u6761\u4ef6\u6279\u51c6\u7684\u53ef\u7528\u6027\u5f81\u8be2\u516c\u4f17\u610f\u89c1\u3002FDA \u6b63\u5728\u8003\u8651\u6839\u636e 2013 \u5e74\u52a8\u7269\u836f\u7269\u4f7f\u7528\u8005\u8d39\u7528\u4fee\u6b63\u6848 (ADUFA III) \u7ee9\u6548\u76ee\u6807\u6269\u5927\u6709\u6761\u4ef6\u6279\u51c6\u7684\u4f7f\u7528\u3002FDA \u6b63\u5728\u63a2\u7d22\u8fd9\u4e00\u53d8\u5316\uff0c\u5e76\u9080\u8bf7\u516c\u4f17\u53d1\u8868\u8bc4\u8bba\u3002\u8bc4\u8bba\u671f\u5c06\u4e8e 2015 \u5e74 3 \u6708 9 \u65e5\u7ed3\u675f\u3002\uff08FDA\uff09<br \/>\n&nbsp;<br \/>\n&gt; \u6b27\u76df \u2013 \u52a8\u7269\u836f\u7269\u6cd5\u89c4 \u6b27\u76df\u59d4\u5458\u4f1a\u901a\u8fc7\u4e86\u5173\u4e8e\u517d\u836f\u548c\u836f\u7269\u9972\u6599\u7684\u63d0\u6848\uff0c\u65e8\u5728\u6539\u5584\u52a8\u7269\u7684\u5065\u5eb7\u548c\u798f\u7949\uff0c\u5e94\u5bf9\u6b27\u76df\u7684\u6297\u83cc\u7d20\u8010\u836f\u6027 (AMR) \u95ee\u9898\u5e76\u4fc3\u8fdb\u521b\u65b0\u3002\u5173\u4e8e\u517d\u836f\u7684\u63d0\u6848\u65e8\u5728\u4f7f\u6b27\u76df\u80fd\u591f\u63d0\u4f9b\u66f4\u591a\u836f\u7269\u6765\u6cbb\u7597\u548c\u9884\u9632\u52a8\u7269\u75be\u75c5\u3002\u5173\u4e8e\u836f\u7269\u9972\u6599\u7acb\u6cd5\u73b0\u4ee3\u5316\u7684\u63d0\u6848\u73b0\u5728\u5c06\u5ba0\u7269\u9972\u6599\u7eb3\u5165\u5176\u8303\u56f4\u3002\u5176\u4ed6\u6b27\u76df\u673a\u6784\u73b0\u5728\u5c06\u6839\u636e\u5171\u540c\u51b3\u7b56\u7a0b\u5e8f\u8003\u8651\u59d4\u5458\u4f1a\u7684\u63d0\u6848\u5e76\u5728\u9002\u5f53\u7684\u65f6\u5019\u91c7\u53d6\u4ed6\u4eec\u7684\u7acb\u573a\u3002 (RTTNews.com)<br \/>\n&nbsp;<br \/>\n&gt; \u7f8e\u56fd \u2013 \u517d\u533b\u5b66\u9662 \u4e9a\u5229\u6851\u90a3\u5927\u5b66\u519c\u4e1a\u4e0e\u751f\u547d\u79d1\u5b66\u5b66\u9662\u5df2\u6536\u5230\u6765\u81ea Kemper \u548c Ethel Marley \u57fa\u91d1\u4f1a\u7684 1490 \u4e07\u7f8e\u5143\u6350\u8d60\uff0c\u7528\u4e8e\u5efa\u7acb\u8be5\u5dde\u9996\u4e2a\u516c\u7acb\u517d\u533b\u533b\u5b66\u548c\u5916\u79d1\u9879\u76ee\uff0c\u4ee5\u57f9\u8bad\u517d\u533b\u533b\u751f\u3002 \u4f4d\u4e8e\u4e9a\u5229\u6851\u90a3\u5dde\u683c\u4f26\u4ee3\u5c14\u7684\u79c1\u7acb\u5927\u5b66\u4e2d\u897f\u90e8\u5927\u5b66\u4e8e 2014 \u5e74\u5f00\u8bbe\u4e86\u517d\u533b\u5b66\u9662\u3002\uff08Vet Advantage\uff09<br \/>\n&nbsp;<br \/>\n************************************<br \/>\n<strong>\u5e03\u62c9\u514b\u54a8\u8be2\u6709\u9650\u516c\u53f8 <br \/>\n\u4ea4\u6613\u534f\u52a9<br \/>\n\u65f6\u673a\u6210\u719f\u65f6<\/strong><\/p>\n<p>\u60f3\u8981\u8d2d\u4e70\u3001\u51fa\u552e\u6216\u5408\u5e76\uff1f\u6211\u4eec\u53ef\u4ee5\u5e2e\u5fd9\uff01<\/p>\n<p>Brakke Consulting \u534f\u52a9\u8bb8\u591a\u5ba2\u6237\u8fdb\u884c\u6280\u672f\u5f15\u8fdb\u548c\u5bf9\u5916\u8bb8\u53ef\u3001\u5408\u5e76\u3001\u6536\u8d2d\u548c\u8d44\u4ea7\u5265\u79bb\u3002\u6211\u4eec\u7684\u4ea4\u6613\u4e13\u5bb6\u53ef\u4ee5\u63d0\u4f9b\u60a8\u5728\u52a8\u7269\u4fdd\u5065\u3001\u5ba0\u7269\u3001\u517d\u533b\u548c\u7279\u79cd\u5316\u5b66\u54c1\u5e02\u573a\u6240\u9700\u7684\u6d1e\u5bdf\u529b\u3001\u80fd\u529b\u548c\u4eba\u8109\u3002\u8bf7\u8054\u7cfb\u6211\u4eec\u7684\u4efb\u4f55\u529e\u4e8b\u5904\u8fdb\u884c\u4fdd\u5bc6\u54a8\u8be2\u3002<br \/>\n&nbsp;<br \/>\n<a href=\"http:\/\/www.BrakkeConsulting.com\">www.BrakkeConsulting.com<\/a> <br \/>\n&nbsp;<br \/>\n************************************<br \/>\nBRAKKE \u54a8\u8be2\u89c2\u70b9<\/p>\n<p>\u76ee\u524d\uff0c\u6211\u4eec\u7684\u8bb8\u591a\u5ba2\u6237\u90fd\u5728\u53c2\u4e0e 2015 \u5e74\u53ca\u4ee5\u540e\u7684\u9884\u7b97\u6d41\u7a0b\u3002\u6211\u4eec\u4ece\u4ed6\u4eec\u90a3\u91cc\u4e86\u89e3\u5230\u4e86\u672a\u6765 18 \u4e2a\u6708\u5bf9\u52a8\u7269\u4fdd\u5065\u7684\u9884\u671f\u3002\u6839\u636e\u5927\u591a\u6570\u516c\u53f8 2014 \u5e74\u524d 6 \u4e2a\u6708\u7684\u6536\u5165\u4ee5\u53ca\u5916\u90e8\u4e00\u822c\u7ecf\u6d4e\u6d88\u8d39\u8005\u62a5\u544a\uff0c\u6211\u4eec\u4ecd\u7136\u8ba4\u4e3a 2015 \u5e74\u53ef\u80fd\u4e0e 2013 \u5e74\u548c 2014 \u5e74\u7684\u60c5\u51b5\u975e\u5e38\u76f8\u4f3c\u3002\u6536\u5165\u589e\u957f\u548c\u5355\u4f4d\u9500\u91cf\u589e\u957f\u5c06\u6709\u9650\u3002\u8be5\u884c\u4e1a\u76ee\u524d\u6b63\u5728\u7ecf\u5386\u4f34\u4fa3\u52a8\u7269\u548c\u98df\u7528\u52a8\u7269\u5e02\u573a\u7684\u6536\u5165\u91cd\u7f6e\u3002\u5236\u9020\u5546\u548c\u5206\u9500\u5546\u7684\u6574\u5408\u5c06\u7ee7\u7eed\u4f7f\u4e00\u4e9b\u516c\u53f8\u7684\u6536\u5165\u589e\u957f\u8d85\u8fc7\u6574\u4e2a\u5e02\u573a\u7684\u589e\u957f\u3002\u90a3\u4e9b\u6ca1\u6709\u91cd\u5927\u65b0\u4ea7\u54c1\u63a8\u51fa\u6216\u6536\u8d2d\u7684\u516c\u53f8\u5c06\u53d1\u73b0\u672a\u6765\u51e0\u4e2a\u5b63\u5ea6\u5145\u6ee1\u6311\u6218\u3002<\/p>\n<p>\u5468\u672b\u6109\u5feb\uff01\u79cb\u5929\u6765\u4e86\uff01<\/p>\n<p>\u7f57\u6069\u00b7\u5e03\u62c9\u514b<br \/>\n&nbsp;<br \/>\n**********************************<br \/>\n\u672c\u7535\u5b50\u901a\u8baf\u5f52 Brakke Consulting, Inc. \u72ec\u6709\u3002<br \/>\n\u5bf9\u672c\u6587\u5185\u5bb9\u7684\u4efb\u4f55\u4f7f\u7528\u5747\u987b\u7ecf\u8fc7 Brakke Consulting, Inc. \u7684\u6279\u51c6\u5e76\u9002\u5f53\u6ce8\u660e\u6765\u6e90\u3002<br \/>\n\u6709\u5173 Brakke Consulting \u670d\u52a1\u548c\u8054\u5408\u7814\u7a76\u7684\u66f4\u591a\u4fe1\u606f\uff0c\u8bf7\u8bbf\u95ee\u6211\u4eec\u7684\u7f51\u7ad9 <a href=\"https:\/\/brakkeconsulting.com\/zh\/\">www.brakkeconsulting.com<\/a>.<br \/>\n&nbsp;<br \/>\nBrakke \u54a8\u8be2\u516c\u53f8<br \/>\n12005 \u798f\u7279\u8def\uff0c530 \u5ba4<br \/>\n\u7f8e\u56fd\u5fb7\u514b\u8428\u65af\u5dde\u8fbe\u62c9\u65af 75234<\/p>\n<p>&nbsp;<\/p>","protected":false},"excerpt":{"rendered":"<p>\u6253\u5370\u7248\u672c ************************************ Brakke Consulting 2014\u5e749\u670812\u65e5\u52a8\u7269\u5065\u5eb7\u65b0\u95fb\u4e0e\u7b14\u8bb0 \u7248\u6743\u6240\u6709 \u00a9 Brakke Consulting, Inc. \u7f16\u8f91\uff1aLynn Fondon DVM MBA ************************************ \u65b0\u95fb\u52a8\u6001\uff1a Brakke Consulting \u65b0\u95fb 2014\u5e74\u72ac\u732b\u764c\u75c7 \u4ea4\u6613\u534f\u52a9 \u6536\u76ca\u65b0\u95fb Big Heart Pet Brands Dechra Genus Sanderson Farms \u5176\u4ed6\u65b0\u95fb Alivira Animal Health InVivo Merck Pancosma Provet Veterinary Products Veterinary Pet Insurance ************************************ \u5341\u6708\u5373\u5c06\u53d1\u5e03 BRAKKE CONSULTING, INC. \u65b0\u62a5\u544a\uff1a2014\u5e74\u72ac\u732b\u764c\u75c7 \u63d0\u65e9\u8ba2\u8d2d\u6298\u6263\u622a\u6b62\u4e8e9\u670819\u65e5\uff01 2009\u5e74\uff0cBrakke Consulting \u53d1\u8868\u4e86\u5173\u4e8e\u72ac\u732b\u764c\u75c7\u6cbb\u7597\u7684\u6982\u8ff0\u3002\u6211\u4eec\u5f88\u9ad8\u5174\u5730\u5ba3\u5e03\uff0c\u8fd9\u4efd\u5907\u53d7\u597d\u8bc4\u7684\u62a5\u544a\u7684\u66f4\u65b0\u7248\u5c06\u4e8e\u4eca\u5e7410\u6708\u53d1\u5e03\u3002 2014\u5e74\u764c\u75c7\u7814\u7a76\u6db5\u76d6\u5e38\u89c1\u517d\u533b\u764c\u75c7\u7684\u53d1\u75c5\u7387\u3001\u8bca\u65ad\u548c\u6cbb\u7597\u4fe1\u606f\uff0c\u5305\u62ec\u6cbb\u7597\u8d39\u7528\u4f30\u7b97\u3002\u8be5\u7814\u7a76\u5305\u62ec\u5bf9250\u540d\u5168\u79d1\u517d\u533b\u7684\u8c03\u67e5\u4ee5\u53ca\u5bf9\u517d\u533b\u80bf\u7624\u5b66\u5bb6\u7684\u8bbf\u8c08\u3002\u62a5\u544a\u8fd8\u5305\u542b\u5bf9\u65b0\u5174\u548c\u6b63\u5728\u7814\u53d1\u7684\u517d\u533b\u764c\u75c7\u5316\u7597\u836f\u7269\u7684\u8bc4\u8bba\u3002\u8be5\u62a5\u544a\u53ef\u9884\u8ba2\uff0c\u9884\u8ba2\u4ef7\u683c\u4e3a$7,750\u82f1\u9551\uff0c\u622a\u6b62\u65e5\u671f\u4e3a9\u670819\u65e5\u3002\u6b32\u4e86\u89e3\u66f4\u591a\u4fe1\u606f\uff0c\u8bf7\u8bbf\u95ee\u6211\u4eec\u7684\u7f51\u7ad9\u6216\u8054\u7cfbLynn Fondon\u535a\u58eb\uff0c\u90ae\u7bb1\u5730\u5740\u4e3alfondon@brakkeconsulting.com\u3002www.BrakkeConsulting.com ************************************ \u516c\u53f8\u4e1a\u7ee9\u62a5\u544a &gt; Dechra Pharmaceuticals\u516c\u5e03\u4e86\u622a\u81f32014\u5e746\u670830\u65e5\u768412\u4e2a\u6708\u4e1a\u7ee9\u3002<\/p>\n<div class=\"view-full-post\"><a href=\"https:\/\/brakkeconsulting.com\/zh\/23904\/\" class=\"view-full-post-btn\">\u67e5\u770b\u5b8c\u6574\u6587\u7ae0<\/a><\/div>\n<p>;<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[1],"tags":[],"class_list":["post-23904","post","type-post","status-publish","format-standard","hentry","category-news"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>News from Brakke Consulting<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/brakkeconsulting.com\/zh\/23904\/\" \/>\n<meta property=\"og:locale\" content=\"zh_CN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"News from Brakke Consulting\" \/>\n<meta property=\"og:description\" content=\"print version *********************************** Brakke Consulting&rsquo;s Animal Health News &amp; Notes for September 12, 2014 Copyright &copy; Brakke Consulting, Inc. &nbsp; Editor: Lynn Fondon DVM MBA ************************************ IN THE NEWS: &nbsp; Brakke Consulting news 2014 Cancer in Dogs and Cats Transaction Assistance &nbsp; earnings news Big Heart Pet Brands Dechra Genus Sanderson Farms &nbsp; other news Alivira Animal Health InVivo Merck Pancosma Provet Veterinary Products Veterinary Pet Insurance&nbsp; &nbsp; ************************************ COMING IN OCTOBER BRAKKE CONSULTING, INC. NEW REPORT: 2014 CANCER IN DOGS AND CATS EARLY-ORDER DISCOUNT ENDS SEPTEMBER 19! In 2009, Brakke Consulting published an overview of the treatment of cancer in dogs and cats. We are pleased to announce that an update of this highly regarded report will be available this October. The 2014 Cancer Study includes information on the incidence, diagnosis, and treatment of the common veterinary cancers, including treatment cost estimates. The study includes a survey of 250 general veterinary practitioners as well as interviews with veterinary oncologists. Reviews of new and developing veterinary cancer chemotherapeutics are included in the report as well. The report is available for pre-order for $7,750 through September 19. For more information, please visit our website or contact Dr. Lynn Fondon at lfondon@brakkeconsulting.com. &nbsp; www.BrakkeConsulting.com &nbsp; ************************************ COMPANY EARNINGS RELEASES &nbsp; &gt; Dechra Pharmaceuticals reported results for the 12 months ended June 30,View Full Post;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/brakkeconsulting.com\/zh\/23904\/\" \/>\n<meta property=\"og:site_name\" content=\"Brakke Consulting Website\" \/>\n<meta property=\"article:published_time\" content=\"2014-09-12T17:51:17+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2018-04-14T07:10:15+00:00\" \/>\n<meta name=\"author\" content=\"Brakke Consulting\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u4f5c\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"Brakke Consulting\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 \u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/brakkeconsulting.com\/23904\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/23904\/\"},\"author\":{\"name\":\"Brakke Consulting\",\"@id\":\"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\"},\"headline\":\"Animal Health News &#038; Notes for September 12, 2014\",\"datePublished\":\"2014-09-12T17:51:17+00:00\",\"dateModified\":\"2018-04-14T07:10:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/brakkeconsulting.com\/23904\/\"},\"wordCount\":1211,\"articleSection\":[\"Newsletter\"],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/brakkeconsulting.com\/23904\/\",\"url\":\"https:\/\/brakkeconsulting.com\/23904\/\",\"name\":\"News from Brakke Consulting\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/#website\"},\"datePublished\":\"2014-09-12T17:51:17+00:00\",\"dateModified\":\"2018-04-14T07:10:15+00:00\",\"author\":{\"@id\":\"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\"},\"breadcrumb\":{\"@id\":\"https:\/\/brakkeconsulting.com\/23904\/#breadcrumb\"},\"inLanguage\":\"zh-Hans\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/brakkeconsulting.com\/23904\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/brakkeconsulting.com\/23904\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/brakkeconsulting.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Animal Health News &#038; Notes for September 12, 2014\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/brakkeconsulting.com\/#website\",\"url\":\"https:\/\/brakkeconsulting.com\/\",\"name\":\"Brakke Consulting Website\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/brakkeconsulting.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\",\"name\":\"Brakke Consulting\",\"url\":\"https:\/\/brakkeconsulting.com\/zh\/author\/i5ww2018\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u6765\u81ea Brakke Consulting \u7684\u65b0\u95fb","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/brakkeconsulting.com\/zh\/23904\/","og_locale":"zh_CN","og_type":"article","og_title":"News from Brakke Consulting","og_description":"print version *********************************** Brakke Consulting&rsquo;s Animal Health News &amp; Notes for September 12, 2014 Copyright &copy; Brakke Consulting, Inc. &nbsp; Editor: Lynn Fondon DVM MBA ************************************ IN THE NEWS: &nbsp; Brakke Consulting news 2014 Cancer in Dogs and Cats Transaction Assistance &nbsp; earnings news Big Heart Pet Brands Dechra Genus Sanderson Farms &nbsp; other news Alivira Animal Health InVivo Merck Pancosma Provet Veterinary Products Veterinary Pet Insurance&nbsp; &nbsp; ************************************ COMING IN OCTOBER BRAKKE CONSULTING, INC. NEW REPORT: 2014 CANCER IN DOGS AND CATS EARLY-ORDER DISCOUNT ENDS SEPTEMBER 19! In 2009, Brakke Consulting published an overview of the treatment of cancer in dogs and cats. We are pleased to announce that an update of this highly regarded report will be available this October. The 2014 Cancer Study includes information on the incidence, diagnosis, and treatment of the common veterinary cancers, including treatment cost estimates. The study includes a survey of 250 general veterinary practitioners as well as interviews with veterinary oncologists. Reviews of new and developing veterinary cancer chemotherapeutics are included in the report as well. The report is available for pre-order for $7,750 through September 19. For more information, please visit our website or contact Dr. Lynn Fondon at lfondon@brakkeconsulting.com. &nbsp; www.BrakkeConsulting.com &nbsp; ************************************ COMPANY EARNINGS RELEASES &nbsp; &gt; Dechra Pharmaceuticals reported results for the 12 months ended June 30,View Full Post;","og_url":"https:\/\/brakkeconsulting.com\/zh\/23904\/","og_site_name":"Brakke Consulting Website","article_published_time":"2014-09-12T17:51:17+00:00","article_modified_time":"2018-04-14T07:10:15+00:00","author":"Brakke Consulting","twitter_card":"summary_large_image","twitter_misc":{"\u4f5c\u8005":"Brakke Consulting","\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4":"6 \u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/brakkeconsulting.com\/23904\/#article","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/23904\/"},"author":{"name":"Brakke Consulting","@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6"},"headline":"Animal Health News &#038; Notes for September 12, 2014","datePublished":"2014-09-12T17:51:17+00:00","dateModified":"2018-04-14T07:10:15+00:00","mainEntityOfPage":{"@id":"https:\/\/brakkeconsulting.com\/23904\/"},"wordCount":1211,"articleSection":["Newsletter"],"inLanguage":"zh-Hans"},{"@type":"WebPage","@id":"https:\/\/brakkeconsulting.com\/23904\/","url":"https:\/\/brakkeconsulting.com\/23904\/","name":"\u6765\u81ea Brakke Consulting \u7684\u65b0\u95fb","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/#website"},"datePublished":"2014-09-12T17:51:17+00:00","dateModified":"2018-04-14T07:10:15+00:00","author":{"@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6"},"breadcrumb":{"@id":"https:\/\/brakkeconsulting.com\/23904\/#breadcrumb"},"inLanguage":"zh-Hans","potentialAction":[{"@type":"ReadAction","target":["https:\/\/brakkeconsulting.com\/23904\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/brakkeconsulting.com\/23904\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/brakkeconsulting.com\/"},{"@type":"ListItem","position":2,"name":"Animal Health News &#038; Notes for September 12, 2014"}]},{"@type":"WebSite","@id":"https:\/\/brakkeconsulting.com\/#website","url":"https:\/\/brakkeconsulting.com\/","name":"Brakke\u54a8\u8be2\u7f51\u7ad9","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/brakkeconsulting.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-Hans"},{"@type":"Person","@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6","name":"\u5e03\u62c9\u514b\u54a8\u8be2\u516c\u53f8","url":"https:\/\/brakkeconsulting.com\/zh\/author\/i5ww2018\/"}]}},"_links":{"self":[{"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/posts\/23904","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/comments?post=23904"}],"version-history":[{"count":1,"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/posts\/23904\/revisions"}],"predecessor-version":[{"id":25463,"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/posts\/23904\/revisions\/25463"}],"wp:attachment":[{"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/media?parent=23904"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/categories?post=23904"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/tags?post=23904"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}